Spit test could predict dangerous drug reaction in leukemia patients
NCT ID NCT03568266
Summary
This study aims to understand why some patients with acute lymphoblastic leukemia (ALL) develop serious liver damage from a key chemotherapy drug called asparaginase. Researchers will collect saliva samples from up to 500 patients to look for specific genetic markers. The goal is to find clues in a person's genes that might predict who is at higher risk for this side effect before treatment begins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
USC / Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.